Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek's disease virus pathogenesis

Avian Diseases

Volumn 50, Issue 1, 2006, Pages 96-103

  Santin, Elizabeth R ^a   Shamblin, Christine E ^b   Prigge, Jonathan T ^c   Arumugaswami, Vaithilingaraja ^d   Dienglewicz, Robert L ^e   Parcells, Mark S ^e,f  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b J CRAIG VENTER INSTITUTE   (United States)

^c CENTER FOR CELL AND GENE THERAPY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ARKANSAS   (United States)

^f UNIVERSITY OF DELAWARE   (United States)

Author keywords

Glycoprotein L; Marek's disease virus; MD pathogenicity; vv+MDV

Indexed keywords

GLYCOPROTEIN L, MAREK'S DISEASE VIRUS; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; BIRD DISEASE; CELL CULTURE; CHICKEN; CYTOLOGY; DISEASE TRANSMISSION; FIBROBLAST; GENETICS; GERMFREE ANIMAL; MONONUCLEAR CELL; MORTALITY; MUTATION; PATHOGENICITY; SPLEEN; VARICELLA ZOSTER VIRUS; VIREMIA; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; CHICKENS; FIBROBLASTS; HERPESVIRUS 1, GALLID; LEUKOCYTES, MONONUCLEAR; MAREK DISEASE; MUTATION; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; VIRAL ENVELOPE PROTEINS; VIREMIA; VIRULENCE; VIRUS REPLICATION;

GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE; MARDIVIRUS; MELEAGRID HERPESVIRUS 1;

EID: 33644942645     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/7273-090704R1.1     Document Type: Article

References (42)

1. Bankowski, R. A., J. E. Moulton, and T. Mikami. Characterization of Cal-1 strain of acute Marek's disease agent. Br. Vet. J. 125:445-453. 1969.
2. Calnek, B. W. Marek's disease vaccines. Dev. Biol. Stand. 52:401-405. 1982.
3. Calnek, B. W., R. W. Harris, C. Buscaglia, K. A. Schat, and B. Lucio. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates. Avian Dis. 42:124-132. 1998.
4. Calnek, B. W., K. A. Schat, M. C. Peckham, and J. Fabricant. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Dis. 27:844-849. 1983.
5. Calnek, B. W., and R. L. Witter. Marek's disease. In: Diseases of poultry, 10th ed. B. W. Calnek, ed. Iowa State University Press, Ames, IA. pp. 367-413. 1997.
6. Cho, B. R. Horizontal transmission of turkey herpesvirus to chickens. IV. Viral maturation in the feather follicle epithelium. Avian Dis. 19:136-141. 1975.
7. Cho, B. R. Marek's disease vaccine breaks: differences in viremia of vaccinated chickens between those with and without Marek's disease. Avian Dis. 20:496-503. 1976.
8. Cho, B. R., and S. G. Kenzy. Horizontal transmission of turkey herpesvirus to chickens. 2. Some factors affecting transmission. Poult. Sci. 52:530-535. 1973.
9. Cho, B. R., and S. G. Kenzy. Horizontal transmission of turkey herpesvirus to chickens. 3. Transmission in three different lines of chickens. Poult. Sci. 54:109-115. 1975.
10. Cho, B. R., S. G. Kenzy, and S. A. Haider. Horizontal transmission of turkey herpesvirus to chickens. 1. Preliminary observation. Poult. Sci. 50:881-887. 1971.
11. Churchill, A. E., and P. M. Biggs. Agent of Marek's disease in tissue culture. Res. Vet. Sci. 8:440-449. 1967.
12. Churchill, A. E., L. N. Payne, and R. C. Chubb. Marek's disease. Immunization against Marek's disease using a live attenuated virus. Lancet 1:610-611. 1969.
13. Eidson, C. S., and S. C. Schmittle. Studies on acute Marek's disease. I. Characteristics of isolate GA in chickens. Avian Dis. 12:522-530. 1968.
14. Khattar, S. K., S. van Drunen Littel-van den Hurk, L. A. Babiuk, and S. K. Tikoo. Identification and transcriptional analysis of a 3′-coterminal gene cluster containing UL1, UL2, UL3, and UL3.5 open reading frames of bovine herpesvirus-1. Virology 213:28-37. 1995.
15. Lee, L. F., X. Liu, J. M. Sharma, K. Nazerian, and L. D. Bacon. A monoclonal antibody reactive with Marek's disease tumor-associated surface antigen. J. Immunol. 130:1007-1011. 1983.
16. Miles, A. M., A. S. Anderson, E. L. Bernberg, J. Kent, J. K. Rosenberger, C. R. Pope, and R. W. Morgan. Comparison of two serotype 1 MDV isolates. Acta Virol. 43:102-105. 1999.
17. Montiel, E. Characterization and control of an emerging Marek's disease virus. Department of Animal and Food Sciences, University of Delaware, Newark, DE. p. 174. 1995.
18. Morgan, R. W., J. L. Cantello, and C. H. McDermott. Transfection of chicken embryo fibroblasts with Marek's disease virus DNA. Avian Dis. 34:345-351. 1990.
19. Nair, V. Evolution of Marek's disease - a paradigm for incessant race between the pathogen and the host. Vet. J. 170:175-183. 2005.
20. Olmeda-Miro, N. In vivo characterization of very virulent Marek's disease virus isolates. Department of Animal and Food Sciences, University of Delaware, Newark, DE. p. 159. 1996.
21. Olmeda-Miro, N., J. K. Rosenberger, S. S. Cloud, and C. R. Pope. In vivo characterization of very virulent Marek's disease virus isolates. In: 68th Northeastern Conference on Avian Diseases. Penn State University Press, Penn State University, PA. pp. 10-12. 1996.
22. Petherbridge, L., A. C. Brown, S. J. Baigent, K. Howes, M. A. Sacco, N. Osterrieder, and V. K. Nair. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J. Virol. 78:13376-13380. 2004.
23. Reddy, S. M., B. Lupiani, I. M. Gimeno, R. F. Silva, L. F. Lee, and R. L. Witter. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. U.S.A. 99:7054-7059. Epub 2002 May 7057. 2002.
24. Rispens, B. H., H. v. Vloten, N. Mastenbroek, H. J. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16:11-19. 1972.
25. Rispens, B. H., H. v. Vloten, N. Mastenbroek, J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 16:139-152. 1972.
26. Rosenberger, J. K., S. S. Cloud, and N. Olmeda-Miro. Epizootiology and adult transmission of Marek's disease. In: Avian tumor virus symposium. A. M. Fadly, K. A. Schat, and J. L. Spencer, eds. AAAP Publishing, Reno, NV. pp. 30-32. 1997.
27. Schat, K. A., and B. W. Calnek. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1141-1146. 1978.
28. Schat, K. A., B. W. Calnek, and J. Fabricant. Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11:593-605. 1982.
29. Shamblin, C. E., N. Greene, V. Arumugaswami, R. L. Dienglewicz, and M. S. Parcells. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. Vet. Microbiol. 102:147-167. 2004.
30. Solomon, J. J., R. L. Witter, K. Nazerian, and B. R. Burmester. Studies on the etiology of Marek's disease. I. Propagation of the agent in cell culture. Proc. Soc. Exp. Biol. Med. 127:177-182. 1968.
31. Velasquez-Levy, Y. S. Characterization of a plaque-purified herpesvirus of turkeys. Department of Animal and Food Sciences, University of Delaware, Newark, DE. p. 94. 1996.
32. Wang, X., W. J. Kenyon, Q. Li, J. Mullberg, and L. M. Hutt-Fletcher. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72:5552-5558. 1998.
33. Westra, D. F., K. L. Glazenburg, M. C. Harmsen, A. Tiran, A. Jan Scheffer, G. W. Welling, T. Hauw The, and S. Welling-Wester. Glycoprotein H of herpes simplex virus type 1 requires glycoprotein L for transport to the surfaces of insect cells. J. Virol. 71:2285-2291. 1997.
34. Witter, R. L. Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Dis. 27:113-132. 1983.
35. Witter, R. L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163. 1997.
36. Witter, R. L. Marek's disease: the continuing struggle between pathogen and host. Vet. J. 170:149-150. 2005.
37. Witter, R. L., G. H. Burgoyne, and J. J. Solomon. Evidence for a herpesvirus as an etiologic agent of Marek's disease. Avian Dis. 13: 211-214. 1969.
38. Witter, R. L., I. M. Gimeno, W. M. Reed, and L. D. Bacon. An acute form of transient paralysis induced by highly virulent strains of Marek's disease virus. Avian Dis. 43:704-720. 1999.
39. Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Biken J. 13:53-57. 1970.
40. Witter, R. L., J. M. Sharma, W. B. Chase, D. A. Halvorson, and V. Sivanandan. Field trials to test the efficacy of polyvalent Marek's disease vaccines in layer and broiler breeder chickens. Poult. Sci. 64:2280-2286. 1985.
41. Witter, R. L., J. M. Sharma, L. F. Lee, H. M. Opitz, and C. W. Henry. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Dis. 28:44-60. 1984.
42. Wu, P., W. M. Reed, and L. F. Lee. Glycoproteins H and L of Marek's disease virus form a hetero-oligomer essential for translocation and cell surface expression. Arch. Virol. 146:983-992. 2001.